Literature DB >> 23871118

Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression.

Laura B Zahodne1, Katherine Ornstein2, Stephanie Cosentino1, D P Devanand3, Yaakov Stern4.   

Abstract

OBJECTIVES: Behavioral and psychological symptoms of dementia (BPSD) are prevalent in Alzheimer disease (AD) and are related to poor outcomes such as nursing home placement. No study has examined the impact of individual BPSD on dependence, a clinically important feature that reflects changing patient needs and their effect on caregivers. The current study characterized independent cross-sectional and longitudinal relationships between three BPSD (psychosis, depressed mood, and agitation/aggression), cognition, and dependence to better understand the interplay between these symptoms over time.
DESIGN: The Predictors Study measured changes in BPSD, cognition, and dependence every 6 months in patients with AD. Cross-sectional and longitudinal relationships between individual BPSD, cognition, and dependence over 6 years were characterized by using multivariate latent growth curve modeling. This approach characterizes independent changes in multiple outcome measures over time.
SETTING: Four memory clinics in the United States and Europe. PARTICIPANTS: A total of 517 patients with probable AD. MEASUREMENTS: Columbia University Scale for Psychopathology, modified Mini-Mental State Examination, and Dependence Scale.
RESULTS: Both psychosis and depressed mood at study entry were associated with worse subsequent cognitive decline. Independent of cognitive decline, initial psychosis was associated with worse subsequent increases in dependence. Rates of increase in agitation/aggression separately correlated with rates of declines in both cognition and independence.
CONCLUSIONS: Although purely observational, our findings support the poor prognosis associated with psychosis and depression in AD. Results also show that agitation/aggression tracks declines in cognition and independence independently over time. Targeted intervention for individual BPSD, particularly psychosis, could have broad effects not only on patient well-being but also on care costs and family burden.
Copyright © 2015 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; depression; statistical modeling

Mesh:

Year:  2013        PMID: 23871118      PMCID: PMC3858495          DOI: 10.1016/j.jagp.2013.03.014

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  40 in total

1.  Neuropathologic correlates of late-onset major depression.

Authors:  Robert A Sweet; Ronald L Hamilton; Meryl A Butters; Benoit H Mulsant; Bruce G Pollock; David A Lewis; Oscar L Lopez; Steven T DeKosky; Charles F Reynolds
Journal:  Neuropsychopharmacology       Date:  2004-12       Impact factor: 7.853

Review 2.  The neurobiology of neuropsychiatric syndromes in dementia.

Authors:  Thomas W Meeks; Susan A Ropacki; Dilip V Jeste
Journal:  Curr Opin Psychiatry       Date:  2006-11       Impact factor: 4.741

3.  New evidence of racial differences in access and their effects on the use of nursing homes among older adults.

Authors:  Adaeze B Akamigbo; Fredric D Wolinsky
Journal:  Med Care       Date:  2007-07       Impact factor: 2.983

4.  Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses.

Authors:  Rodney C P Go; Rodney T Perry; Howard Wiener; Susan S Bassett; Deborah Blacker; Bernie Devlin; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

5.  Major depression as a risk factor for early institutionalization of dementia patients living in the community.

Authors:  Pascale Dorenlot; Marc Harboun; Vincent Bige; Jean-Claude Henrard; Joël Ankri
Journal:  Int J Geriatr Psychiatry       Date:  2005-05       Impact factor: 3.485

6.  The effects of patient function and dependence on costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

7.  APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease.

Authors:  S Cosentino; N Scarmeas; E Helzner; M M Glymour; J Brandt; M Albert; D Blacker; Y Stern
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

8.  The relation of patient dependence to home health aide use in Alzheimer's disease.

Authors:  Rachel K Scherer; Nikolaos Scarmeas; Jason Brandt; Deborah Blacker; Marilyn S Albert; Yaakov Stern
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-09       Impact factor: 6.053

9.  Patient dependence and longitudinal changes in costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Arthur S Zbrozek; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  Dement Geriatr Cogn Disord       Date:  2008-10-22       Impact factor: 2.959

10.  Cognitive and behavioural predictors of progression rates in Alzheimer's disease.

Authors:  I Buccione; R Perri; G A Carlesimo; L Fadda; L Serra; S Scalmana; C Caltagirone
Journal:  Eur J Neurol       Date:  2007-04       Impact factor: 6.089

View more
  31 in total

1.  Social cognition in Alzheimer's disease: a separate construct contributing to dependence.

Authors:  Stephanie Cosentino; Laura B Zahodne; Jason Brandt; Deborah Blacker; Marilyn Albert; Bruno Dubois; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-18       Impact factor: 21.566

2.  State of the Science: Apathy As a Model for Investigating Behavioral and Psychological Symptoms in Dementia.

Authors:  Lauren Massimo; Helen C Kales; Ann Kolanowski
Journal:  J Am Geriatr Soc       Date:  2018-04       Impact factor: 5.562

3.  Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.

Authors:  Winnie Qian; Corinne E Fischer; Tom A Schweizer; David G Munoz
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

Review 4.  Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?

Authors:  Damien Gallagher; Nathan Herrmann
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

5.  Beyond memory: a focus on the other neuropsychiatric symptoms of dementia.

Authors:  Matthew E Peters; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2015-02       Impact factor: 4.105

6.  The neural signatures of psychoses in Alzheimer's disease: a neuroimaging genetics approach.

Authors:  Riccardo Manca; Antonio F Pardiñas; Annalena Venneri
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-21       Impact factor: 5.270

Review 7.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

8.  Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia.

Authors:  Deepa Acharya; David G Harper; Eric D Achtyes; Stephen J Seiner; Jack A Mahdasian; Louis J Nykamp; Lesley Adkison; Lori Van der Schuur White; Shawn M McClintock; Manjola Ujkaj; Donald A Davidoff; Brent P Forester
Journal:  Int J Geriatr Psychiatry       Date:  2014-05-16       Impact factor: 3.485

9.  Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment.

Authors:  Barbara Resnick; Ann Kolanowski; Kimberly Van Haitsma; Elizabeth Galik; Marie Boltz; Jeanette Ellis; Liza Behrens; Karen Eshraghi; Shijun Zhu
Journal:  Clin Nurs Res       Date:  2019-04-03       Impact factor: 2.075

10.  Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.

Authors:  Myuri Ruthirakuhan; Zahinoor Ismail; Nathan Herrmann; Damien Gallagher; Krista L Lanctôt
Journal:  Alzheimers Dement       Date:  2022-02-01       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.